Filing Details

Accession Number:
0001193805-21-000599
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-04 13:00:00
Reporting Period:
2021-05-04
Accepted Time:
2021-05-04 12:34:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785530 Werewolf Therapeutics Inc. HOWL () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1009258 Deerfield Management Company, L.p. (Series C) 345 Park Avenue South,
12Th Floor
New York NY 10010
No No Yes Yes
1010823 L.p. Mgmt Deerfield 345 Park Avenue South,
12Th Floor
New York NY 10010
No No Yes Yes
1301041 Deerfield Partners, L.p. 345 Park Avenue South
12Th Floor
New York NY 10010
No No Yes Yes
1352546 E James Flynn 345 Park Avenue South,
12Th Floor
New York NY 10010
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-04 1,752,787 $0.00 1,752,787 No 4 C Indirect Through Deerfield Partners, L.P.
Common Stock Acquisiton 2021-05-04 800,000 $16.00 2,552,787 No 4 P Indirect Through Deerfield Partners, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Through Deerfield Partners, L.P.
No 4 P Indirect Through Deerfield Partners, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2021-05-04 15,195,094 $0.00 1,752,787 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. Each share of Series B Preferred Stock automatically converted into .1154 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering (on an adjusted basis, after giving effect to the 1-for-8.6691 reverse split of the Issuer's common stock effected by the Issuer on April 23, 2021).
  2. This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (the "Fund"). Deerfield Management Company, L.P. is the investment manager of the Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.
  3. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.